Biotie Therapies Corp - Company & Market Research Reports

Biotie is a biopharmaceutical company focused on products for neurodegenerative and psychiatric disorders. Its best known product to-date is Selincro for alcohol dependence, which received European marketing authorization in 2013. It currently has a number of products in development, including tozadenant for Parkinson's disease and two compounds for cognitive disorders. Biotie Therapies Corp. is headquartered in Turku, Finland. As of April 18, 2016, it operates as a subsidiary of Acorda Therapeutics, Inc.


The 2018-2023 World Outlook for Smoking Cessation Medicines - Product Thumbnail Image

The 2018-2023 World Outlook for Smoking Cessation Medicines

  • Report
  • 292 Pages
Global Alzheimer's Therapeutics Market Analysis 2016 - Forecast to 2022 - Product Thumbnail Image

Global Alzheimer's Therapeutics Market Analysis 2016 - Forecast to 2022

  • Report
  • 138 Pages
From
Global Alzheimer's Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2015 to 2022 - Product Thumbnail Image

Global Alzheimer's Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2015 to 2022

  • Report
From
Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market) - Product Thumbnail Image

Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market)

  • Report
  • 106 Pages
From
Alzheimer's Drugs Market, 2012 - 2017 - Product Thumbnail Image

Alzheimer's Drugs Market, 2012 - 2017

  • Report
  • 117 Pages
From
Alzheimer's Disease: Clinical Pipelines, R&D Challenges, and Future Directions - Product Thumbnail Image

Alzheimer's Disease: Clinical Pipelines, R&D Challenges, and Future Directions

  • Report
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015 - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015

  • Report
  • 235 Pages
From
Rheumatoid Arthritis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics - Global Strategic Business Report

  • Report
  • 824 Pages
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • 611 Pages
From
Anti-Parkinson's Drugs: Global Markets to 2022 - Product Thumbnail Image

Anti-Parkinson's Drugs: Global Markets to 2022

  • Report
  • 172 Pages
From
Global Parkinson's Disease Market Analysis 2016 - Forecast to 2022 - Product Thumbnail Image

Global Parkinson's Disease Market Analysis 2016 - Forecast to 2022

  • Report
  • 122 Pages
From
Parkinson's Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments - Product Thumbnail Image

Parkinson's Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments

  • Report
  • 136 Pages
From
Global Parkinson’s Disease Market Report: 2016 Edition - Product Thumbnail Image

Global Parkinson’s Disease Market Report: 2016 Edition

  • Report
  • 51 Pages
From
5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H1 2018 - Product Thumbnail Image

5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H1 2018

  • Report
  • 69 Pages
From
Primary Sclerosing Cholangitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Primary Sclerosing Cholangitis - Pipeline Review, H1 2018

  • Report
  • 106 Pages
From
Primary Sclerosing Cholangitis - Pipeline Review, H2 2017 - Product Thumbnail Image

Primary Sclerosing Cholangitis - Pipeline Review, H2 2017

  • Report
  • 91 Pages
From
Inflammation - Pipeline Review, H1 2014 - Product Thumbnail Image

Inflammation - Pipeline Review, H1 2014

  • Report
  • 1103 Pages
From
Competitor Analysis - Antibody Therapy of Inflammatory and Autoimmune Diseases - Product Thumbnail Image

Competitor Analysis - Antibody Therapy of Inflammatory and Autoimmune Diseases

  • Report
  • 172 Pages
From
Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas - Product Thumbnail Image

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

  • Report
  • 540 Pages
From
Biotie Therapies Corp. - Product Pipeline Review - 2015 - Product Thumbnail Image

Biotie Therapies Corp. - Product Pipeline Review - 2015

  • Company Profile
  • 34 Pages
From
Loading Indicator
adroll